News tagged with clinical oncology
Antidepressant eases radiation-related mouth pain in head, neck cancer
An oral rinse of the antidepressant doxepin significantly eased pain associated with oral mucositis in patients receiving radiation therapy for cancers of the head and neck, a study led by Mayo Clinic found. The findings ...
Cancer
Oct 29, 2012 |
not rated yet |
0
Language, immigration status of hispanic caregivers impacted care of children with cancer
Language barriers and the immigration status of caregivers appear to impact the care of Hispanic children with cancer and affect the experience of the families within the medical system, according to data presented at the ...
Cancer
Oct 29, 2012 |
not rated yet |
0
Older breast cancer patients see more complications with brachytherapy
heralded for its low complication rates—actually results in more complications than whole-breast radiation one year after treatment, Yale School of Medicine researchers report in the October issue of the Journal of Clinical On ...
Cancer
Oct 22, 2012 |
not rated yet |
0
|
Social outcomes good for most pediatric brain tumor survivors
(HealthDay)—While the majority of survivors of pediatric embryonal tumors display positive social outcomes several years after diagnosis and treatment, specific risk factors may affect social adjustment ...
Cancer
Oct 21, 2012 |
not rated yet |
0
Lexatumumab tolerated for pediatric solid tumors
(HealthDay)—Lexatumumab, an agonistic, full human monoclonal antibody against tumor necrosis factor-related apoptosis-inducing ligand receptor 2, is well tolerated and may lessen certain clinical symptoms ...
Cancer
Oct 16, 2012 |
5 / 5 (1) |
0
Patient-reported outcomes essential to comparative effectiveness research
Patient-reported outcomes should be a standard part of evaluating the comparative effectiveness of cancer treatments, according to recommendations put forward by a multi-institution research group.
Cancer
Oct 16, 2012 |
not rated yet |
0
Gene signature validated for oral cancer metastases
(HealthDay)—A multigene signature effectively predicts the presence of lymph node metastases in squamous cell carcinoma of the oral cavity (OSCC) and oropharynx (OPSCC), according to a study published online ...
Cancer
Oct 14, 2012 |
not rated yet |
0
HIV status doesn't influence Hodgkin's lymphoma outcome
(HealthDay)—Despite more extensive disease and more adverse prognostic factors, HIV-positive patients with Hodgkin's lymphoma (HL) do not have worse outcomes when treated with doxorubicin, bleomycin, vinblastine, ...
Cancer
Oct 11, 2012 |
not rated yet |
0
Interventions helpful for breast cancer-induced menopause
(HealthDay)—Cognitive behavioral therapy (CBT) and physical exercise improve endocrine and urinary symptoms as well as physical functioning in patients with breast cancer treatment-induced menopause, according ...
Cancer
Oct 11, 2012 |
not rated yet |
0
Scientists identify genetic signatures for aggressive form of prostate cancer
Scientists have discovered two separate genetic 'signatures' for prostate cancer that appear to be able to predict the severity of the disease, leading to hopes that in future, accuracy of prognosis and treatment of the disease ...
Cancer
Oct 08, 2012 |
5 / 5 (1) |
0
|
BMI and lean body mass decline after allogeneic HSCT
(HealthDay)—In survivors of childhood hematologic malignancies who have received allogeneic hematopoietic stem cell transplantation (alloHSCT), body mass index (BMI) decreases significantly, mainly due ...
Cancer
Oct 04, 2012 |
2 / 5 (1) |
0
Are too few women being offered breast-conserving treatment?
Two new studies presented at the ESMO 2012 Congress in Vienna, Austria show how improvements in breast cancer treatments are making it possible for more women to conserve their breasts following therapy, but raise concerns ...
Cancer
Sep 30, 2012 |
not rated yet |
0
Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer
Treatment with the drug sorafenib as a third or fourth line therapy does not result in improved overall survival among patients with advanced non-small cell lung cancer (NSCLC), according to findings released at the ESMO ...
Cancer
Sep 29, 2012 |
not rated yet |
0
Short-, long-course therapy comparable in T3 rectal cancer
(HealthDay)—There are no statistically significant differences in the rates of local recurrence (LR), distant recurrence, relapse-free survival, overall survival, or late toxicity in patients treated with ...
Cancer
Sep 27, 2012 |
not rated yet |
0
Watch-and-wait OK in low-tumor burden follicular lymphoma
(HealthDay)—An initial watch-and-wait strategy does not have a detrimental effect on the freedom from treatment failure (FFTF) or overall survival rate in selected patients with low-tumor burden follicular ...
Cancer
Sep 26, 2012 |
5 / 5 (1) |
0
